Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook

62°
- Sweetwater, TX (79556)
  Today
  
  Rain likely. High 66F. WSW winds shifting to NNW at 10 to 15 mph. Chance of rain 100%. Rainfall near a quarter of an inch..
  
  Tonight
  
  Cloudy skies this evening will become partly cloudy after midnight. Slight chance of a rain shower. Low 41F. Winds NNE at 5 to 10 mph.
  
  Updated: February 10, 2026 @ 10:41 am
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
- Place an ad
Archives
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

0.8122 +0.0982 (+13.75%)

Streaming Delayed Price Updated: 12:26 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Immunic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 18, 2025

Via Benzinga

This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

September 29, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...

Via Benzinga

This VSE Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

September 29, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...

Via Benzinga

Immunic (IMUX) Q2 Loss Widens 25% ↗

August 07, 2025

Via The Motley Fool

IMUX Stock Earnings: Immunic Misses EPS for Q1 2024 ↗

May 08, 2024

IMUX stock results show that Immunic missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial ↗

July 07, 2025

Via Stocktwits

Immunic to Participate in Scientific and Industry Conferences in May ↗

July 07, 2025

Via Stocktwits

Topics Economy

Immunic, Inc. Announces Proposed Public Offering ↗

July 07, 2025

Via Stocktwits

Topics Regulatory Compliance

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering ↗

July 07, 2025

Via Stocktwits

Immunic to Participate in Investor, Scientific and Industry Conferences in June ↗

July 02, 2025

Via Stocktwits

Topics Intellectual Property

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering ↗

July 02, 2025

Via Stocktwits

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS ↗

July 02, 2025

Via Stocktwits

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis ↗

July 02, 2025

Via Stocktwits

Let's take a look at the stocks that are in motion in today's session. ↗

May 29, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 28, 2025

Via Benzinga

Wednesday's session: top gainers and losers ↗

April 30, 2025

Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 30, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

April 30, 2025

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

These stocks that are showing activity before the opening bell on Wednesday. ↗

April 30, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 30, 2025

Via Benzinga

Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Mode ↗

April 09, 2025

Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.

Via Stocktwits

Topics Intellectual Property Lawsuit

This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday ↗

September 16, 2024

Via Benzinga

Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying ↗

May 23, 2024

While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying.

Via InvestorPlace

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day

May 20, 2024

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day

Via News Direct

Immunic chief medical officer discusses promising treatments to mark World IBD Day

May 17, 2024

Immunic chief medical officer discusses promising treatments to mark World IBD Day

Via News Direct

Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day

May 16, 2024

Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day

Via News Direct

Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones

May 09, 2024

Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones

Via News Direct

Topics Intellectual Property

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

May 01, 2024

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

Via News Direct

Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month

March 21, 2024

--News Direct--

Via News Direct

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Business
Entertainment
Obituaries
Local Events
Photos
Videos
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Sweetwater Reporter

sweetwaterreporter.com
112 West Third Street
Sweetwater, TX 79556
Phone: 325-236-6677
Email: editor@sweetwaterreporter.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Sweetwater, TX (79556)

Today

Tonight

Immunic, Inc. - Common Stock (NQ:IMUX)

Headline News about Immunic, Inc. - Common Stock

Sections

Services

Sweetwater Reporter